Salifluss®

400mg tablets containing carnosine & hibiscus sabdariffa L., in a muco-adhesive matrix

Salifluss® designed for treatment of dry mouth symptoms & complications

Dual action tablet that promotes both Saliva Production1, 2 and Acid Regulation1, 2

References

  1. Levrini et al. (2020). The Efficacy of a Dietary Supplement with Carnosine and Hibiscus Sabdariffa L. (AqualiefTM). Clin Ter, 171 (4), e295-301.
  2. Iacovelli et al. (2021). Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients. 13, 3456.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Kora Healthcare at pv@korahealthcare.com or on 01904 217 755.